FDA Adverse Event Injury Summary report: N

SOFTFORM FACIAL IMPLANT

MDR report key: 173926 · Received June 22, 1998

Report

Report Number
2027148-1998-00039
Event Type
Injury
Date Received
June 22, 1998
Date of Event
February 10, 1998
Report Date
June 22, 1998
Manufacturer
TISSUE TECHNOLOGIES, INC.
Product Code
FTL
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
PHYSICIAN

Narratives

Description of Event or Problem · 1

PT IMPLANTED INTO THE NASOLABIAL FOLDS. VASOTEC, PREMARIA, PROVERA, VITAMEN E, CALCIUM, MINOCYCLINE, HEAD ELEVATION, COOL COMPRESSES AND BACITRACIN PRESCRIBED TO 12/08/1997. ONSET OF INFECTION AND IMPLANT DISPLACEMENT IN NASOLABIAL FOLD AREA 12/15/1997. 12/17/1997 SEPTRA PRESCRIBED. 2/10/1998 REMOVAL DIFFICULTIES IN EXPLANTING DEVICE. SEPTRA AND BACETRACIN PRESCRIBED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 SOFTFORM FACIAL IMPLANT Implant SOFTFORM FTL TISSUE TECHNOLOGIES, INC. NA K03449/97K101A

Patients

Seq Age Sex Outcome Treatment
1 47 YR Required Intervention 9. BACITRACIN (12/08/1997 TO 12/12/1997).| 5. CALCIUM (FROM 12/08/1997),| 4. VITAMIN E (FROM 12/08/1997),| 3. PROVERA (FROM 12/08/1997),| 6. MINOCYCLINE (12/08/1997 TO 12/15/1997),| 8. COOL COMPRESSES (12/08/1997 TO 12/10/1997),| 1. VASOTEC (FROM 12/08/1997),| 7. HEAD ELECATION (12/08/1997 TO 12/11/1997),| 2. PREMARIN (FROM 12/08/1997),